Literature DB >> 1730257

Pre-B lymphocyte-specific transcriptional control of the mouse VpreB gene.

T Okabe1, S R Bauer, A Kudo.   

Abstract

The VpreB genes, which encode surrogate immunoglobulin light chain molecules, are expressed as RNA almost exclusively in pre-B cells. We have investigated the transcriptional control mechanisms which are responsible for the pre-B cell-specific RNA expression of the mouse VpreB1 and VpreB2 genes. Nuclear run-on analyses demonstrate that the pre-B cell-specific expression of both VpreB genes is controlled primarily at the level of initiation of transcription. S1 nuclease protection-mapping defined two or three major start sites of transcription for the VpreB genes. To find a promoter and other potential cis-acting regulatory elements, a 700-bp fragment 5' of the transcription start sites of the VpreB1 gene was used in gene transfer experiments and found to act as a promoter in pre-B lymphocytes. Deletion experiments showed that 191 bp upstream of the most 5' transcription start site is required for the pre-B cell promoter activity. DNA sequence analysis of the 5' region of the mouse VpreB1, VpreB2 and human VpreB genes reveal that this region of approximately 200 bp is strongly conserved. This 200-bp promoter region contains several conserved nucleotide sequence motifs which may act to mediate the pre-B cell-specific transcription of the VpreB genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730257     DOI: 10.1002/eji.1830220106

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Review article: role of the surrogate light chain and the pre-B-cell receptor in mouse B-cell development.

Authors:  I L Mårtensson; R Ceredig
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

2.  Distinct factors regulate the murine RAG-2 promoter in B- and T-cell lines.

Authors:  J Lauring; M S Schlissel
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  Silencer elements controlling the B29 (Igbeta) promoter are neither promoter- nor cell-type-specific.

Authors:  C S Malone; S A Omori; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

4.  Modulated expression of the epidermal growth factor-like homeotic protein dlk influences stromal-cell-pre-B-cell interactions, stromal cell adipogenesis, and pre-B-cell interleukin-7 requirements.

Authors:  S R Bauer; M J Ruiz-Hidalgo; E K Rudikoff; J Goldstein; J Laborda
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

5.  MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures.

Authors:  Andrea Zangrando; Marta Campo Dell'orto; Geertruy Te Kronnie; Giuseppe Basso
Journal:  BMC Med Genomics       Date:  2009-06-23       Impact factor: 3.063

6.  Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells.

Authors:  Kuo-I Lin; Cristina Angelin-Duclos; Tracy C Kuo; Kathryn Calame
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

7.  A novel gene product associated with mu chains in immature B cells.

Authors:  T Shirasawa; K Ohnishi; S Hagiwara; K Shigemoto; Y Takebe; K Rajewsky; T Takemori
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

8.  Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia.

Authors:  Y Minegishi; E Coustan-Smith; Y H Wang; M D Cooper; D Campana; M E Conley
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

9.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-10-25       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.